All ProductsDisplaying Products by Catalog Number (6900 - 6999)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
Cat. No. | 产品名称/活性 |
---|---|
6900 | NNMTi |
Nicotinamide N-methyltransferase (NNMT) inhibitor; promotes myoblast differentiation | |
6902 | Dapansutrile |
NLRP3 inflammasome inhibitor; disrupts inflammasome formation | |
6903 | DPTIP |
Potent and selective N-SMase2 inhibitor; brain penetrant | |
6904 | Idasanutlin |
Potent MDM2 inhibitor; inhibits MDM2-p53 interaction | |
6905 | Ceritinib |
Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3 | |
6907 | VH 032 amide-PEG2-amine |
VHL ligand with PEG linker and terminal amine for onward chemistry | |
6908 | TR 14035 |
Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable | |
6909 | VH 032 phenol-alkylC4-amine |
VHL ligand with alkyl linker and terminal amine for onward chemistry | |
6910 | VH 032 phenol-alkylC6-amine |
VHL ligand with alkyl linker and terminal amine for onward chemistry | |
6911 | VH 032, phenol |
Hydroxyl functionalized VHL ligand | |
6912 | dTAG-7 |
First generation Degrader for mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation | |
6913 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine |
Cereblon ligand with alkyl-PEG-alkyl linker and terminal amine for onward chemistry | |
6914 | dTAGV-1 |
Potent and selective degrader of mutant FKBP12F36V fusion proteins | |
6915 | dTAGV-1-NEG |
Negative control for dTAGV-1 (Cat. No. 6914) | |
6916 | dTAG-13-NEG |
Negative control for dTAG-13 (Cat. No. 6605) | |
6917 | Thalidomide 4'-ether-alkylC4-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6921 | BSJ-03-123 |
Selective Cdk6 Degrader (PROTAC®) | |
6923 | AMZ 30 |
Potent, selective and irreversible protein phosphatase methylesterase-1 (PME-1) inhibitor | |
6925 | NBC 6 |
NLRP3 inflammasome inhibitor | |
6927 | Glucagon (Human, Porcine) |
Endogenous glucagon receptor agonist | |
6928 | VU 6001966 |
Potent and selective negative allosteric modulator of mGlu2 receptors | |
6930 | Amphotericin B |
Forms monovalent ion channels in lipid bilyers; antifungal | |
6931 | AF 64394 |
Potent and selective GPR3 inverse agonist | |
6935 | GSK J5 HCl |
Inactive isomer of GSK J4 (Cat. No. 4594); cell permeable | |
6936 | VZ 185 |
Potent and selective BRD7/9 Degrader (PROTAC®) | |
6937 | BSJ-04-132 |
Selective Cdk4 Degrader (PROTAC®) | |
6938 | BSJ-03-204 |
Selective Cdk4/6 Degrader (PROTAC® | |
6939 | cis-VZ 185 |
Negative control for VZ 185 (Cat. No. 6936) | |
6940 | BTD |
Selective TRPC5 activator | |
6941 | Pyr 10 |
Selective TRPC3 inhibitor | |
6943 | dBRD9-A |
Potent BRD9 Degrader (PROTAC®) | |
6944 | Pomalidomide 4'-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6945 | dBET6 |
Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo | |
6946 | Thalidomide 4'-oxyacetamide-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6948 | CRBN-6-5-5-VHL |
Potent and selective cereblon Degrader (PROTAC®); cell-permeable | |
6949 | Thalidomide 4'-oxyacetamide-alkylC2-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6950 | Thalidomide 4'-ether-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6951 | Thalidomide 4'-ether-PEG5-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6952 | VH 101, phenol |
Hydroxyl functionalized VHL ligand | |
6954 | L-Buthionine sulfoximine |
Irreversible γ-glutamylcysteine synthetase (γ-GCS) inhibitor; induces ferroptosis | |
6955 | Ceapin A7 |
Selective inhibitor of ATF6α; sensitizes cells to ER stress | |
6956 | Galunisertib |
ALK4 and ALK5 (TGFβRI) inhibitor | |
6960 | ABT 199 |
Selective, high affinity Bcl-2 inhibitor; orally bioavailable | |
6961 | FzM1.8 |
Frizzled 4 allosteric agonist; exhibits biased signaling; preserves stemness | |
6962 | JBJ-03-142-02 |
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | |
6963 | Pomalidomide 4'-PEG4-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6964 | LY 2119620 |
Positive allosteric modulator of M2 and M4 receptors | |
6965 | CGI 1746 |
Potent, reversible BTK inhibitor | |
6966 | Thalidomide 4'-oxyacetamide-PEG1-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6967 | Thalidomide 4'-oxyacetamide-PEG2-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
6968 | Thalidomide 4'-oxyacetamide-alkylC6-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
6969 | cis VH 032, amine dihydrochloride |
Negative control for VH 032, amine (Cat. No. 6462) | |
6970 | aTAG 2139 |
Degrader of MTH1 fusion proteins for use within the aTAG system | |
6971 | aTAG 4531 |
Degrader of MTH1 fusion proteins for use within the aTAG system | |
6972 | A 1899 |
Potent K2P3.1 (TASK-1) and K2P9.1 (TASK-3) blocker | |
6973 | NS 3728 |
VRAC blocker | |
6975 | Teniposide |
DNA topoisomerase II inhibitor; viral transduction enhancer | |
6976 | JNJ 10198409 |
Potent PDGFRα and PDGFRβ inhibitor; also inhibits c-Abl, Lck, c-Src and Fyn kinases | |
6977 | Bobcat339 |
Ten-eleven translocation methylcytosine dioxygenase (TET) inhibitor | |
6978 | AZD 5363 |
Potent pan-AKT inhibitor | |
6979 | SEN 177 |
Potent glutaminyl cyclase inhibitor; disrupts binding of SIRP-α to CD47 | |
6981 | TL 0259 |
Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable | |
6982 | Cyclosporin H |
Enhances lentiviral transduction | |
6984 | KIN001-266 |
Potent and selective Tpl2 (MAP3K8) inhibitor | |
6985 | VH 032 amide-alkylC5-amine |
VHL ligand with alkyl linker and terminal amine for onward chemistry | |
6986 | EG 00229 trifluoroacetate |
Neuropilin 1 (NRP1) receptor antagonist; inhibits VEGFA binding to NRP1 | |
6990 | SET 2 |
Selective TRPV2 antagonist | |
6993 | Janelia Fluor® 646, free acid |
Red dye (Reactive group: free acid). Application: flow cytometry, confocal microscopy, super resolution microscopy (SRM) including dSTORM & STED. Suitable for live cell imaging | |
6996 | BOP-JF549 |
Yellow fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 549; fluorogenic; photostable | |
6997 | BOP-JF646 |
Red fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 646; fluorogenic; photostable | |
6998 | SHIN 1 |
Potent SHMT inhibitor |